← Back to Search

Motivational Interviewing and COVID-19 Symptom Monitoring System for COVID-19

N/A
Waitlist Available
Led By Mary Cwik, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Tribal members who live within an approximately 1-hour radius of the Indian Health Service (IHS) /Tribal health facility within each of the three participating sites (Whiteriver, Arizona; Chinle, Arizona; Shiprock, New Mexico).
Elder participants must be ≥65 years old at the time of recruitment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints).
Awards & highlights

Study Summary

This study is evaluating whether a new approach to testing for colon cancer may improve the rate of early detection.

Eligible Conditions
  • COVID-19
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints).
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CHANGE IN PROTECTIVE BEHAVIORS Over time - Recommended Practices
PROTECTIVE BEHAVIORS - Days quarantined in the past month
PROTECTIVE BEHAVIORS - Vaccine Acceptance
+2 more
Secondary outcome measures
Anxiety
Cultural Identity and Connectedness
Demographic
+2 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: MotivationaI Interviewing and COVID-19 Symptom Monitoring System GroupExperimental Treatment2 Interventions
Participants in this group will receive both motivational interviewing and daily COVID-19 symptom (CS) text-based monitoring system. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Group II: MotivationaI Interviewing GroupExperimental Treatment2 Interventions
Participants in this study group will receive a brief, culturally appropriate, and age-tailored motivational interviewing (MI) intervention targeting facilitators and barriers to appropriate testing, isolation, and care-seeking among young adults and elders. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental, or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Group III: Control GroupExperimental Treatment1 Intervention
Participants in this group will only receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask wearing, how to prevent the spread in the home and managing stress during COVID-19
Group IV: COVID-19 Symptom Monitoring System GroupExperimental Treatment2 Interventions
Participants in this study group will receive daily COVID-19 symptom (CS) text-based monitoring system to prompt more rapid testing at the onset of symptoms. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Symptom Monitoring System
2021
N/A
~70
Motivational Interviewing and COVID-19 Symptom Monitoring System
2021
N/A
~70
Motivational Interviewing
2020
Completed Phase 3
~8850

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
410 Previous Clinical Trials
2,116,886 Total Patients Enrolled
5 Trials studying COVID-19
3,300 Patients Enrolled for COVID-19
Mary Cwik, PhDPrincipal InvestigatorJohns Hopkins University
4 Previous Clinical Trials
719 Total Patients Enrolled
Laura Hammitt, MDPrincipal InvestigatorJohns Hopkins University
3 Previous Clinical Trials
1,033 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Mar 2025